Review: taking Prednisone and Neurontin together


Summary

Drug interactions are reported among people who take Prednisone and Neurontin together. This review analyzes the effectiveness and drug interactions between Prednisone and Neurontin. It is created by eHealthMe based on reports of 7,818 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Prednisone and Neurontin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Prednisone

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. (latest outcomes from Prednisone 169,045 users)

Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 63,468 users)

On Aug, 20, 2016

7,818 people who take Prednisone, Neurontin are studied.


Number of reports submitted per year:

Prednisone and Neurontin drug interactions.

Drug effectiveness over time:

Prednisone:
  • < 1 month: 14.0% - (3 of 21 people)
  • 1 - 6 months: 20.0% - (5 of 24 people)
  • 6 - 12 months: 75.0% - (3 of 4 people)
  • 1 - 2 years: 57.0% - (4 of 7 people)
  • 2 - 5 years: 38.0% - (7 of 18 people)
  • 5 - 10 years: 75.0% - (9 of 12 people)
  • 10+ years: 50.0% - (3 of 6 people)
  • not specified: 0.0% - (0 of 1 people)
Neurontin:
  • < 1 month: 26.0% - (4 of 15 people)
  • 1 - 6 months: 11.0% - (2 of 17 people)
  • 6 - 12 months: 7.0% - (1 of 13 people)
  • 1 - 2 years: 23.0% - (4 of 17 people)
  • 2 - 5 years: 21.0% - (4 of 19 people)
  • 5 - 10 years: 33.0% - (3 of 9 people)
  • 10+ years: 33.0% - (1 of 3 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Prednisone:
  • female: 35.0% - (27 of 76 people)
  • male: 41.0% - (7 of 17 people)
Neurontin:
  • female: 21.0% - (16 of 76 people)
  • male: 17.0% - (3 of 17 people)

Drug effectiveness by age:

Prednisone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 14.0% - (1 of 7 people)
  • 30-39: 25.0% - (3 of 12 people)
  • 40-49: 17.0% - (3 of 17 people)
  • 50-59: 40.0% - (9 of 22 people)
  • 60+: 52.0% - (18 of 34 people)
Neurontin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 14.0% - (1 of 7 people)
  • 30-39: 0.0% - (0 of 11 people)
  • 40-49: 23.0% - (4 of 17 people)
  • 50-59: 32.0% - (8 of 25 people)
  • 60+: 18.0% - (6 of 32 people)

Most common drug interactions over time *:

< 1 month:
  • gastroenteritis viral
  • anaemia
  • nausea
  • thrombocytopenia
  • aspartate aminotransferase increased
  • alanine aminotransferase increased
  • myelodysplastic syndrome
  • pain
  • dehydration
  • pyrexia
1 - 6 months:
  • cellulitis
  • abdominal pain
  • anaemia
  • hidradenitis
  • weakness
  • hypotension
  • pneumonia
  • cardiac arrest
  • cardiac tamponade
  • drug ineffective
6 - 12 months:
  • anaemia
  • fall
  • insomnia
  • urinary tract infection
  • oedema peripheral
  • pain in extremity
  • pneumonia
  • dehydration
  • granuloma
  • neuropathy peripheral
1 - 2 years:
  • joint pain
  • cellulitis
  • hypothyroidism postoperative
  • dizziness
  • cerebrovascular accident
  • asthenia
  • dysstasia
  • eye swelling
  • eyelid oedema
  • lip swelling
2 - 5 years:
  • anxiety
  • depression
  • suicide attempt
  • pain
  • hives
  • itching
  • pulmonary embolism
  • rash generalised
  • urticaria
  • chest pain
5 - 10 years:
  • anxiety
  • asthma
  • atrial fibrillation
  • depression
  • edema - peripheral, peripheral edema
  • intentional overdose
  • suicide attempt
  • vascular calcification
  • weight decreased
  • emotional distress
10+ years:
  • cellulitis
  • joint pain
  • hypothyroidism postoperative
  • fall
  • hypoaesthesia
  • nephrogenic systemic fibrosis
  • confusional state
  • memory impairment
  • anxiety
  • difficulty in walking
not specified:
  • pain
  • anxiety
  • nausea
  • fatigue
  • arthralgia
  • back pain
  • dyspnoea
  • anaemia
  • fall
  • pneumonia

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • nausea
  • fall
  • arthralgia
  • fatigue
  • pain in extremity
  • oedema peripheral
  • dyspnoea
  • headache
male:
  • pain
  • anxiety
  • anaemia
  • back pain
  • pneumonia
  • osteonecrosis of jaw
  • dyspnoea
  • fatigue
  • arthralgia
  • asthenia

Most common drug interactions by age *:

0-1:
  • orthostatic hypotension
  • blood cholesterol increased
  • gallbladder operation
  • sensation of foreign body
  • type 2 diabetes mellitus
  • gastrointestinal haemorrhage
  • respiratory distress
2-9:
  • lymphopenia
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • gamma-glutamyltransferase increased
  • adenovirus infection
  • hepatic steatosis
  • convulsion
  • gastroenteritis viral
  • heart rate increased
  • hepatitis infectious
10-19:
  • impaired gastric emptying
  • pain
  • crohn's disease
  • haematemesis
  • gastroenteritis
  • general physical health deterioration
  • pancreatitis
  • vision blurred
  • weight increased
  • abdominal pain
20-29:
  • pain
  • vomiting
  • pain in extremity
  • arthralgia
  • pyrexia
  • oedema peripheral
  • dyspnoea
  • diarrhoea
  • drug ineffective
  • nausea
30-39:
  • nausea
  • oedema peripheral
  • pain
  • anxiety
  • pain in extremity
  • arthralgia
  • back pain
  • dyspnoea
  • fatigue
  • abdominal pain
40-49:
  • pain
  • anxiety
  • arthralgia
  • nausea
  • fatigue
  • oedema peripheral
  • dyspnoea
  • pain in extremity
  • headache
  • anaemia
50-59:
  • pain
  • anxiety
  • fatigue
  • arthralgia
  • anaemia
  • nausea
  • depression
  • headache
  • fall
  • back pain
60+:
  • pain
  • pneumonia
  • fall
  • anxiety
  • back pain
  • anaemia
  • nausea
  • dyspnoea
  • osteonecrosis of jaw
  • arthralgia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Prednisone and Neurontin?

Can you answer these questions?

More questions for: Prednisone, Neurontin

You may be interested in these reviews

More reviews for: Prednisone, Neurontin

On eHealthMe, Prednisone (prednisone) is often used to treat rheumatoid arthritis. Neurontin (gabapentin) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.